Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesic Efficacy of Regional Blocks After Uniportal VATS
NCT05094323Phase 2Completed
- Sponsor
- Assiut University
- Start
- Feb 2022
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of bupivacaine in postoperative pain (3 arms), sponsored by Assiut University. Primary endpoint: Time to first analgesic requirement at 24 hours. Started Feb 2022; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05094323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05094323.